Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study

Trial Profile

Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Mar 2013

At a glance

  • Drugs Trichuris suis ova (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TRIMS-A
  • Most Recent Events

    • 08 Jan 2013 New trial record
    • 06 Nov 2012 New source identified and integrated (EudraCT2008-007549-29: European Clinical Trials Database).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top